Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy

This study aimed to analyze the treatment and outcomes of older glioblastoma patients. Forty-four patients older than 70 years of age were referred to the Paul Strauss Center for chemotherapy and radiotherapy. The median age was 75.5 years old (range: 70–84), and the patients included 18 females and...

Full description

Bibliographic Details
Main Authors: Georges Noël, Pierre Kehrli, Roland Schott, Céline Vigneron, Nicolas Bauer, Jean-Baptiste Clavier, Sokha Eav, Hélène Nehme-Schuster, Delphine Antoni, Ludovic T. Nguyen, Socheat Touch
Format: Article
Language:English
Published: MDPI AG 2013-09-01
Series:Cancers
Subjects:
hypofractionated radiotherapy
chemotherapy
elderly
Online Access:http://www.mdpi.com/2072-6694/5/3/1177

Internet

http://www.mdpi.com/2072-6694/5/3/1177

Similar Items